Broncus Medical Inc (Broncus) is a medical device company that develops navigation, diagnostic and therapeutic technologies for the treatment of patients with lung disease. The company offers the Archimedes system, a total lung access platform used for virtual bronchoscopic planning, navigation and tunneling. It also provides Archimedes Planner, a portable pre-procedure planning and simulation system for Archimedes and FlexNeedle, a transbronchial aspiration needle. The company offers Lungpoint Virtual Bronchoscopic Navigation (VBN) system that provides real-time path navigation within the lungs for lung biopsy and other DX/TX procedures; and Lungpoint Planner, a portable pre-procedure planning and simulation system for VBN. Broncus is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Broncus Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Broncus Medical Inc Company Overview
- Broncus Medical Inc Company Snapshot
- Broncus Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Broncus Medical Inc - Pipeline Analysis Overview
- Broncus Medical Inc - Key Facts
- Broncus Medical Inc - Major Products and Services
- Broncus Medical Inc Pipeline Products by Development Stage
- Broncus Medical Inc Ongoing Clinical Trials by Trial Status
- Broncus Medical Inc Pipeline Products Overview
- Bronchoscope Guided Microwave Ablation (MWA) System
- Bronchoscope Guided Microwave Ablation (MWA) System Product Overview
- Exhale Drug Eluting Stent
- Exhale Drug Eluting Stent Product Overview
- Intervapor System
- Intervapor System Product Overview
- Intervapor System Clinical Trial
- Intervapor System - Lung Cancer
- Intervapor System - Lung Cancer Product Overview
- New-Generation Navigation Software
- New-Generation Navigation Software Product Overview
- Percutaneous RFA Probe
- Percutaneous RFA Probe Product Overview
- Radiofrequency Device - Lung Nodules
- Radiofrequency Device - Lung Nodules Product Overview
- Radiofrequency Device - Lung Nodules Clinical Trial
- RF Generator + RF Ablation Catheter
- RF Generator + RF Ablation Catheter Product Overview
- RF-SEG Generator + RF-iCon Ablation Catheter (RF-II)
- RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) Product Overview
- Targeted Lung Denervation Radiofrequency Ablation System
- Targeted Lung Denervation Radiofrequency Ablation System Product Overview
- Targeted Lung Denervation Radiofrequency Ablation System Clinical Trial
- Broncus Medical Inc - Key Competitors
- Broncus Medical Inc - Key Employees
- Broncus Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Broncus Medical Inc, Recent Developments
- Jun 13, 2024: Broncus Medical Receives 510(K) Clearance For BroncTru Transbronchial Access Tool
- May 07, 2024: Broncus Medical Receives 510(K) Clearance For BioStar cTBNA/EBUS-TBNA Needle
- Sep 18, 2023: Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
- Sep 18, 2023: Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
- Jul 10, 2023: Broncus completes first operation in radiofrequency ablation system trial
- Jul 18, 2022: Broncus completed surgeries on the first group of patients using its Intervapor, the thermal vapor treatment system, after approved for marketing in China
- Mar 25, 2022: New study shows virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping using broncus Archimedes System is safe and effective in obtaining high biopsy yield in lung tumors
- Mar 21, 2022: Intervapor, thermal vapor treatment system, approved for marketing in China
- Dec 10, 2021: Enrollment for registered clinical trials successfully completed for RF-II in China
- Sep 30, 2021: Broncus completed the first-in-man clinical trial of its Targeted Lung Denervation Radiofrequency Ablation System
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Broncus Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Broncus Medical Inc Pipeline Products by Equipment Type
- Broncus Medical Inc Pipeline Products by Indication
- Broncus Medical Inc Ongoing Clinical Trials by Trial Status
- Broncus Medical Inc, Key Facts
- Broncus Medical Inc, Major Products and Services
- Broncus Medical Inc Number of Pipeline Products by Development Stage
- Broncus Medical Inc Pipeline Products Summary by Development Stage
- Broncus Medical Inc Ongoing Clinical Trials by Trial Status
- Broncus Medical Inc Ongoing Clinical Trials Summary
- Bronchoscope Guided Microwave Ablation (MWA) System - Product Status
- Bronchoscope Guided Microwave Ablation (MWA) System - Product Description
- Exhale Drug Eluting Stent - Product Status
- Exhale Drug Eluting Stent - Product Description
- Intervapor System - Product Status
- Intervapor System - Product Description
- Intervapor System - To Evaluate Lung Cancer Tumor Ablation Using Intervapor Targeted Vapor Therapy: First-in-human Study
- Intervapor System - Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Definitive Treatment Study
- Intervapor System - Lung Cancer - Product Status
- Intervapor System - Lung Cancer - Product Description
- New-Generation Navigation Software - Product Status
- New-Generation Navigation Software - Product Description
- Percutaneous RFA Probe - Product Status
- Percutaneous RFA Probe - Product Description
- Radiofrequency Device - Lung Nodules - Product Status
- Radiofrequency Device - Lung Nodules - Product Description
- Radiofrequency Device - Lung Nodules - Transbronchial Versus Transthoracic Ablation for Early Stage Peripheral Lung Cancer: A Prospective, Randomized Controlled Trial
- RF Generator + RF Ablation Catheter - Product Status
- RF Generator + RF Ablation Catheter - Product Description
- RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) - Product Status
- RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) - Product Description
- Targeted Lung Denervation Radiofrequency Ablation System - Product Status
- Targeted Lung Denervation Radiofrequency Ablation System - Product Description
- Targeted Lung Denervation Radiofrequency Ablation System - A Multicenter, Randomized, Single-blind, Sham-controlled Clinical Trial Evaluating the Safety and Effectiveness of Pulmonary Denervation Radiofrequency Ablation Devices in the Treatment of Chronic Obstructive Pulmonary Disease
- Targeted Lung Denervation Radiofrequency Ablation System - A Multicenter, Randomized, Single-blind, Sham-controlled Clinical Trial to Evaluate the Safety and Effectiveness of Targeted Lung Denervation Radiofrequency Ablation Devices in the Treatment of Chronic Obstructive Pulmonary Disease
- Broncus Medical Inc, Key Employees
- Broncus Medical Inc, Subsidiaries
- Broncus Medical Inc, Joint Venture
- Glossary
- Broncus Medical Inc Pipeline Products by Equipment Type
- Broncus Medical Inc Pipeline Products by Development Stage
- Broncus Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardious Inc
- BirdSong Medical Devices Inc
- Bio-Med Devices Inc
